Your browser doesn't support javascript.
loading
A longitudinal approach to biological psychiatric research: The PsyCourse study.
Budde, Monika; Anderson-Schmidt, Heike; Gade, Katrin; Reich-Erkelenz, Daniela; Adorjan, Kristina; Kalman, Janos L; Senner, Fanny; Papiol, Sergi; Andlauer, Till F M; Comes, Ashley L; Schulte, Eva C; Klöhn-Saghatolislam, Farah; Gryaznova, Anna; Hake, Maria; Bartholdi, Kim; Flatau, Laura; Reitt, Markus; Quast, Silke; Stegmaier, Sophia; Meyers, Milena; Emons, Barbara; Haußleiter, Ida Sybille; Juckel, Georg; Nieratschker, Vanessa; Dannlowski, Udo; Schaupp, Sabrina K; Schmauß, Max; Zimmermann, Jörg; Reimer, Jens; Schulz, Sybille; Wiltfang, Jens; Reininghaus, Eva; Anghelescu, Ion-George; Arolt, Volker; Baune, Bernhard T; Konrad, Carsten; Thiel, Andreas; Fallgatter, Andreas J; Figge, Christian; von Hagen, Martin; Koller, Manfred; Lang, Fabian U; Wigand, Moritz E; Becker, Thomas; Jäger, Markus; Dietrich, Detlef E; Stierl, Sebastian; Scherk, Harald; Spitzer, Carsten; Folkerts, Here.
Afiliación
  • Budde M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Anderson-Schmidt H; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Gade K; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.
  • Reich-Erkelenz D; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Adorjan K; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.
  • Kalman JL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Senner F; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Papiol S; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Andlauer TFM; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Comes AL; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Schulte EC; International Max Planck Research School for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Klöhn-Saghatolislam F; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Gryaznova A; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Hake M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Bartholdi K; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Flatau L; Department of Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Reitt M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Quast S; International Max Planck Research School for Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Stegmaier S; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Meyers M; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Emons B; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Haußleiter IS; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Juckel G; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Nieratschker V; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Dannlowski U; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Schaupp SK; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Schmauß M; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.
  • Zimmermann J; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.
  • Reimer J; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Schulz S; Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.
  • Wiltfang J; Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.
  • Reininghaus E; Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.
  • Anghelescu IG; Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany.
  • Arolt V; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Baune BT; Department of Psychiatry, University of Münster, Münster, Germany.
  • Konrad C; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Thiel A; Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, Augsburg, Germany.
  • Fallgatter AJ; Department of Psychiatry and Psychotherapy, Bezirkskrankenhaus Augsburg, Augsburg, Germany.
  • Figge C; Psychiatrieverbund Oldenburger Land gGmbH, Karl-Jaspers-Klinik, Bad Zwischenahn, Germany.
  • von Hagen M; Department of Psychiatry, Klinikum Bremen-Ost, Bremen, Germany.
  • Koller M; Department of Psychiatry, Klinikum Bremen-Ost, Bremen, Germany.
  • Lang FU; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.
  • Wigand ME; German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.
  • Becker T; iBiMED, Medical Sciences Department, University of Aveiro, Aveiro, Portugal.
  • Jäger M; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.
  • Dietrich DE; Department of Psychiatry, Dr. Fontheim-Mental Health, Liebenburg, Germany.
  • Stierl S; Department of Psychiatry, University of Münster, Münster, Germany.
  • Scherk H; Discipline of Psychiatry, Royal Adelaide Hospital, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
  • Spitzer C; Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg, Germany.
  • Folkerts H; Department of Psychiatry and Psychotherapy, Agaplesion Diakonieklinikum, Rotenburg, Germany.
Am J Med Genet B Neuropsychiatr Genet ; 180(2): 89-102, 2019 03.
Article en En | MEDLINE | ID: mdl-30070057
ABSTRACT
In current diagnostic systems, schizophrenia and bipolar disorder are still conceptualized as distinct categorical entities. Recently, both clinical and genomic evidence have challenged this Kraepelinian dichotomy. There are only few longitudinal studies addressing potential overlaps between these conditions. Here, we present design and first results of the PsyCourse study (N = 891 individuals at baseline), an ongoing transdiagnostic study of the affective-to-psychotic continuum that combines longitudinal deep phenotyping and dimensional assessment of psychopathology with an extensive collection of biomaterial. To provide an initial characterization of the PsyCourse study sample, we compare two broad diagnostic groups defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) classification system, that is, predominantly affective (n = 367 individuals) versus predominantly psychotic disorders (n = 524 individuals). Depressive, manic, and psychotic symptoms as well as global functioning over time were contrasted using linear mixed models. Furthermore, we explored the effects of polygenic risk scores for schizophrenia on diagnostic group membership and addressed their effects on nonparticipation in follow-up visits. While phenotypic results confirmed expected differences in current psychotic symptoms and global functioning, both manic and depressive symptoms did not vary between both groups after correction for multiple testing. Polygenic risk scores for schizophrenia significantly explained part of the variability of diagnostic group. The PsyCourse study presents a unique resource to research the complex relationships of psychopathology and biology in severe mental disorders not confined to traditional diagnostic boundaries and is open for collaborations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastornos Mentales Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Med Genet B Neuropsychiatr Genet Asunto de la revista: GENETICA MEDICA / NEUROLOGIA / PSIQUIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastornos Mentales Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Med Genet B Neuropsychiatr Genet Asunto de la revista: GENETICA MEDICA / NEUROLOGIA / PSIQUIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania
...